120 related articles for article (PubMed ID: 1156553)
1. Serum anti-tumour antibodies and auto-antibodies in vitiligo.
Woolfson H; Finn OA; Mackie RM; McQueen A; MacSween RN
Br J Dermatol; 1975 Apr; 92(4):395-400. PubMed ID: 1156553
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.
Merimsky O; Shoenfeld Y; Yecheskel G; Chaitchik S; Azizi E; Fishman P
Cancer Immunol Immunother; 1994 Jun; 38(6):411-6. PubMed ID: 8205563
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. I. Circulating antibodies for cultured melanoma cells.
Takei M; Mishima Y; Uda H
J Cutan Pathol; 1984 Apr; 11(2):107-13. PubMed ID: 6376558
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
Hann SK; Kim JB
Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
[TBL] [Abstract][Full Text] [Related]
5. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
6. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
Galbraith GM; Miller D; Emerson DL
Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
Fishman P; Merimski O; Baharav E; Shoenfeld Y
Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo and malignant melanoma: a significant association?
Gregor RT
S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
[TBL] [Abstract][Full Text] [Related]
9. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
Seibert E; Sorg C; Happle R; Macher E
Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
Naughton GK; Eisinger M; Bystryn JC
J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
[TBL] [Abstract][Full Text] [Related]
11. Epidermal cytoplasmic antibodies. (Incidence and clinical significance).
Betterle C; Peserico A; Bersani G; Rigon F; Del Prete G
Ric Clin Lab; 1977; 7(3):242-51. PubMed ID: 343221
[TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte transformation by melanin antigens in vitiligo vulgaris and malignant melanoma (author's transl)].
Yamada M; Fujimoto F; Higashi K; Yanase K; Oku T
Nihon Hifuka Gakkai Zasshi; 1975 May; 85(6):351-8. PubMed ID: 1081153
[No Abstract] [Full Text] [Related]
13. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of antismooth muscle antibody in Korean vitiligo patients.
Hann SK; Im S; Kim HI; Kim HS; Lee YJ; Park YK
J Dermatol; 1993 Nov; 20(11):679-83. PubMed ID: 8300936
[TBL] [Abstract][Full Text] [Related]
15. Immunological associations of the halo naevus with cutaneous malignant melanoma.
Copeman PW; Lewis MG; Phillips TM; Elliott PG
Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
[No Abstract] [Full Text] [Related]
16. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to normal human melanocytes in vitiligo.
Naughton GK; Eisinger M; Bystryn JC
J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-associated hypopigmentation: where are the antibodies?
Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P
Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in patients with vitiligo.
Brostoff J
Lancet; 1969 Jul; 2(7613):177-8. PubMed ID: 4183134
[No Abstract] [Full Text] [Related]
20. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
Ackermann-Schopf CM
Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
